291 related articles for article (PubMed ID: 35835621)
1. Siglecs in allergy and asthma.
Bochner BS; O'Sullivan JA; Chang AT; Youngblood BA
Mol Aspects Med; 2023 Apr; 90():101104. PubMed ID: 35835621
[TBL] [Abstract][Full Text] [Related]
2. Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases.
O'Sullivan JA; Youngblood BA; Schleimer RP; Bochner BS
Semin Immunol; 2023 Sep; 69():101799. PubMed ID: 37413923
[TBL] [Abstract][Full Text] [Related]
3. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil and mast cell Siglecs: From biology to drug target.
O'Sullivan JA; Chang AT; Youngblood BA; Bochner BS
J Leukoc Biol; 2020 Jul; 108(1):73-81. PubMed ID: 31965606
[TBL] [Abstract][Full Text] [Related]
5. Siglecs as Immune Cell Checkpoints in Disease.
Duan S; Paulson JC
Annu Rev Immunol; 2020 Apr; 38():365-395. PubMed ID: 31986070
[TBL] [Abstract][Full Text] [Related]
6. Structural advances of Siglecs: insight into synthetic glycan ligands for immunomodulation.
Movsisyan LD; Macauley MS
Org Biomol Chem; 2020 Aug; 18(30):5784-5797. PubMed ID: 32756649
[TBL] [Abstract][Full Text] [Related]
7. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.
Bochner BS
Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537
[TBL] [Abstract][Full Text] [Related]
8. Non-canonical roles of Siglecs: Beyond sialic acid-binding and immune cell modulation.
Siddiqui SS
Mol Aspects Med; 2023 Apr; 90():101145. PubMed ID: 36153172
[TBL] [Abstract][Full Text] [Related]
9. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
Crocker PR
Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
[TBL] [Abstract][Full Text] [Related]
10. Functions and therapeutic targets of Siglec-mediated infections, inflammations and cancers.
Lin CH; Yeh YC; Yang KD
J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):5-24. PubMed ID: 31882261
[TBL] [Abstract][Full Text] [Related]
11. Human sialoglycan ligands for immune inhibitory Siglecs.
Gonzalez-Gil A; Li TA; Kim J; Schnaar RL
Mol Aspects Med; 2023 Apr; 90():101110. PubMed ID: 35965135
[TBL] [Abstract][Full Text] [Related]
12. Basic and clinical immunology of Siglecs.
von Gunten S; Bochner BS
Ann N Y Acad Sci; 2008 Nov; 1143():61-82. PubMed ID: 19076345
[TBL] [Abstract][Full Text] [Related]
13. Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides.
Rapoport EM; Pazynina GV; Sablina MA; Crocker PR; Bovin NV
Biochemistry (Mosc); 2006 May; 71(5):496-504. PubMed ID: 16732727
[TBL] [Abstract][Full Text] [Related]
14. [Research progress on the role and clinical application of Siglecs in tumor immunity].
Chen H; Lu J; Wang D; Sui L; Xu S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Dec; 39(12):1125-1131. PubMed ID: 38140873
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
16. Roles of the Siglec family in bone and bone homeostasis.
Ye Z; Wang Y; Xiang B; Wang H; Tao H; Zhang C; Zhang S; Sun D; Luo F; Song L
Biomed Pharmacother; 2023 Sep; 165():115064. PubMed ID: 37413904
[TBL] [Abstract][Full Text] [Related]
17. Preparation of Recombinant Siglecs and Identification of Their Ligands.
Chang LY; Low PY; Sridharan D; Gerlovin K; Angata T
Methods Mol Biol; 2020; 2132():85-98. PubMed ID: 32306317
[TBL] [Abstract][Full Text] [Related]
18. Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments.
Gianchecchi E; Arena A; Fierabracci A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071314
[TBL] [Abstract][Full Text] [Related]
19. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
Cao H; Crocker PR
Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
[TBL] [Abstract][Full Text] [Related]
20. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
Angata T; Varki A
J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
